These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 6199591)

  • 21. Involvement of epinephrine in the presynaptic beta adrenoceptor mechanism of norepinephrine release from rat hypothalamic slices.
    Ueda H; Goshima Y; Kubo T; Misu Y
    J Pharmacol Exp Ther; 1985 Feb; 232(2):507-12. PubMed ID: 2982014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1980 May; 213(2):406-13. PubMed ID: 6102602
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacodynamic effects of prenalterol in healthy subjects.
    Johnsson G
    Acta Med Scand Suppl; 1982; 659():109-22. PubMed ID: 6127882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenalterol is an agonist at beta 2- as well as at beta 1-adrenoceptors.
    Apperley GH; Drew GM; Sullivan AT
    Eur J Pharmacol; 1982 Jul; 81(4):659-63. PubMed ID: 6126381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basic pharmacological properties of prenalterol.
    Mattsson H; Hedberg A; Carlsson E
    Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
    [No Abstract]   [Full Text] [Related]  

  • 26. Myocardial sensitivity to isoproterenol following abrupt propranolol withdrawal in conscious dogs.
    Webb JG; Newman WH; Walle T; Daniell HB
    J Cardiovasc Pharmacol; 1981; 3(3):622-35. PubMed ID: 6168842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardioselectivity of prenalterol and isoproterenol.
    Jennings G; Bobik A; Oddie C; Hargreaves M; Korner P
    Clin Pharmacol Ther; 1983 Dec; 34(6):749-57. PubMed ID: 6641090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulation.
    Osborn JL; DiBona GF; Thames MD
    J Pharmacol Exp Ther; 1981 Feb; 216(2):265-9. PubMed ID: 6257884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The measurement of the relative efficacy of agonists by selective potentiation of tissue responses: studies with isoprenaline and prenalterol in cardiac tissue.
    Kenakin TP; Beek D
    J Auton Pharmacol; 1984 Sep; 4(3):153-9. PubMed ID: 6208197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of chronic beta-adrenoceptor activation on neurotensin-induced myocardial effects in rats.
    Osadchii O; Norton G; Deftereos D; Muller D; Woodiwiss A
    Eur J Pharmacol; 2006 Dec; 553(1-3):246-53. PubMed ID: 17056037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta 1-and beta 2-adrenoceptor stimulatory effects of prenalterol.
    Mattsson H; Andersson T; Carlsson E; Hedberg A; Lundgren B; Olsson T
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):302-8. PubMed ID: 6132344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of evidence for beta-2 receptor selectivity: a study of metaproterenol, fenoterol, isoproterenol, and epinephrine in patients with asthma.
    Burgess CD; Windom HH; Pearce N; Marshall S; Beasley R; Siebers RW; Crane J
    Am Rev Respir Dis; 1991 Feb; 143(2):444-6. PubMed ID: 1671326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age, hypertension, and cardiac responses to beta-agonist in humans.
    White M; Fourney A; Leenen FH
    Clin Pharmacol Ther; 1998 Jun; 63(6):663-71. PubMed ID: 9663181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of beta-1-adrenergic agonists in the treatment of cardiac insufficiency].
    Coulombe D
    Ann Cardiol Angeiol (Paris); 1984; 33(4):207-10. PubMed ID: 6147113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inotropic and sympathetic responses to the intracoronary infusion of a beta2-receptor agonist: a human in vivo study.
    Newton GE; Azevedo ER; Parker JD
    Circulation; 1999 May; 99(18):2402-7. PubMed ID: 10318661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of preserved baseline cardiac systolic function in rats with adrenergic inotropic downregulation.
    Osadchii O; Woodiwiss A; Alves N; Norton G
    Life Sci; 2005 Dec; 78(4):366-75. PubMed ID: 16137710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
    Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
    J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosterone.
    Arrizabalaga P; Montoliu J; Martinez Vea A; Andreu L; López Pedret J; Revert L
    Proc Eur Dial Transplant Assoc; 1983; 20():572-6. PubMed ID: 6318223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of hemodynamic responses to isoproterenol infusion and surgical stress in patients given cardioselective and noncardioselective beta-adrenergic antagonists.
    de Bruijn N; Reves JG; Croughwell N; Knopes K
    Anesth Analg; 1987 Jul; 66(7):637-42. PubMed ID: 2886078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of selective and nonselective beta adrenergic agents on renin secretion in isolated perfused rat kidney.
    Nakane H; Nakane Y; Roux A; Corvol P; Menard J
    J Pharmacol Exp Ther; 1980 Jan; 212(1):34-8. PubMed ID: 6101342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.